Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,352.00    -49.50 (-1.12%)
Bid:
4,353.50
Ask:
4,354.00
Spread: 0.50 (0.011%)
Market Cap: £94.24b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Share Buy-Back Programme completes

3 Dec 2021 15:37

RNS Number : 5726U
Unilever PLC
03 December 2021
Β 

Unilever completes share buyback programme

3 December 2021

Β 

London - Unilever PLC announces the successful completion of the second tranche of its share buyback programme initially announced on 29 April 2021 (the 'Second Tranche'). Under the Second Tranche, which began on 23 August 2021, 32,508,415 Unilever PLC shares were purchased with a total value equivalent of approximately €1,499,999,934.

Β 

Under the first tranche of this buyback programme, which began on 6 May 2021 and completed on 13 August 2021, 30,467,730 Unilever PLC shares were purchased.

Β 

All of the shares purchased in the buyback programme have been placed in treasury. As a result, Unilever PLC holds a total of 62,976,145 shares in treasury and has a total of 2,566,267,627 non-treasury shares in issue. Of the non-treasury shares in issue, a total of 5,301,252 shares (including shares represented by Unilever PLC ADSs) are held by or on behalf of companies in the Unilever group (the 'Unilever Group Shares'). The voting rights attaching to the Unilever Group Shares are not exercisable.

Β 

With the completion of the Second Tranche, Unilever has delivered on its intention, as announced on 29 April 2021, to buy back shares with an aggregate market value equivalent of up to €3 billion.

Β 

Please see the total voting rights announcement dated 1 December 2021 for Unilever PLC's latest total voting rights figure published under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.

Β 

Β 

Unilever PLC

Unilever House100 Victoria EmbankmentLondon EC4Y 0DYUnited Kingdom

Press-Office.London@Unilever.com

Β 

Β 

CAUTIONARY STATEMENT

Β 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

Β 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Β 

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2020 and the Unilever Annual Report and Accounts 2020 available on our corporate website.Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSBUBDDSXGDGBX
Date   Source Headline
22nd Jul 20202:42 pmRNSNotice of Separate Adjourned Meetings
22nd Jul 20202:32 pmRNSUnilever Announces Results of Bondholder Meetings
13th Jul 20209:00 amRNSExtension of Early Instruction Deadline
9th Jul 202012:34 pmRNSDirector/PDMR Shareholding
26th Jun 20201:30 pmRNSDIP – Notice of Separate Meetings
26th Jun 20201:15 pmRNSConsent Solicitations
11th Jun 20207:00 amRNSUnification of Unilever’s legal structure
9th Jun 20201:47 pmRNSDirector/PDMR Shareholding
5th Jun 202011:29 amRNSDirector/PDMR Shareholding
12th May 20201:22 pmRNSDirector/PDMR Shareholding
30th Apr 202011:45 amRNSMembership of Board Committees
29th Apr 20204:56 pmRNSDirector/PDMR Shareholding
29th Apr 20203:52 pmRNSResult of AGM
27th Apr 20206:00 pmRNSListing Rule 9.2.6E statement
23rd Apr 20207:00 amRNS1st Quarter 2020 Trading Statement
20th Apr 20205:20 pmRNSUnilever Annual General Meetings update
9th Apr 202011:44 amRNSDirector/PDMR Shareholding
1st Apr 20201:15 pmRNSCompletion of Horlicks acquisition from GSK
30th Mar 202012:30 pmRNSDirector/PDMR Shareholding
24th Mar 20204:43 pmRNSSecond Price Monitoring Extn
24th Mar 20204:37 pmRNSPrice Monitoring Extension
24th Mar 202012:00 pmRNSPublication of Final Terms
24th Mar 202011:00 amRNSHelping to protect lives and livelihoods: Covid-19
23rd Mar 20206:13 pmRNSDirector/PDMR Shareholding
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
19th Mar 20202:59 pmRNSDirector/PDMR Shareholding
19th Mar 202010:45 amRNSNotice of AGM update
19th Mar 202010:20 amRNSNotice of AGM
13th Mar 20203:45 pmRNSPublication of Suppl.Prospcts
10th Mar 202011:24 amRNSDirector/PDMR Shareholding
10th Mar 20207:30 amRNSAnnual Financial Report
4th Mar 20202:30 pmRNSBoard Composition Announcement
20th Feb 20203:09 pmRNSDirector/PDMR Shareholding
18th Feb 20204:10 pmRNSDirector/PDMR Shareholding
11th Feb 20201:51 pmRNSDirector/PDMR Shareholding
5th Feb 202010:42 amRNSDirector/PDMR Shareholding
30th Jan 20207:00 amRNSFinal Results
10th Jan 202012:08 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSUnilever Sales Update
11th Dec 20193:06 pmRNSDirector/PDMR Shareholding
9th Dec 20195:10 pmRNSDirector/PDMR Shareholding
5th Dec 201912:47 pmRNSDirector/PDMR Shareholding
13th Nov 20197:00 amRNSUnilever Chairman announcement
11th Nov 20193:02 pmRNSDirector/PDMR Shareholding
17th Oct 20197:00 amRNS3rd Quarter Trading Statement
10th Oct 20199:17 amRNSDirector/PDMR Shareholding
18th Sep 20192:00 pmRNSTreatment of hyperinflationary countries
16th Sep 20195:42 pmRNSDirector/PDMR Shareholding
12th Sep 20198:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.